Abstract
Transcatheter aortic valve implantation (TAVI) is increasingly used to treat younger patients with longer life expectancy. Consequently, it can be expected that a considerable portion of these patients will outlive their transcatheter aortic valve (TAV). In the event of TAV failure, redo-TAVI may be the preferred solution. However, redo-TAVI outcomes may vary depending on the patient’s anatomy and TAV-in-TAV combination. In this viewpoint, we highlight different TAV stent designs and leaflet positions and discuss their impact on specific aspects of TAV-in-TAV.
Original language | English |
---|---|
Journal | EuroIntervention |
Volume | 19 |
Issue number | 9 |
Pages (from-to) | 714-716 |
Number of pages | 3 |
ISSN | 1774-024X |
DOIs | |
Publication status | Published - 2023 |
Externally published | Yes |